HDL cholesterol
Increase · moderate
PPAR-δ activation
Literature evidence
Compound library
Vivy evidence dossier
Cardarine
T2General Wellness
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Observed relationships
Biomarker context
Triglycerides
Decrease · moderate
Improves lipid oxidation
Literature evidence
LDL cholesterol
Decrease · small
Improves lipid profile
Literature evidence
Exercise tolerance
Increase · moderate
Enhanced fatty acid oxidation
Literature evidence
CRP
Decrease · small
Anti-inflammatory effects
Literature evidence
Fasting glucose
Decrease · small
Improves insulin sensitivity
Literature evidence
HbA1c
Decrease · small
Improves glycemic control
Literature evidence
Body fat
Decrease · small
Improves fat metabolism
Literature evidence
ApoB
Decrease · small
Improves lipid profile
Literature evidence
LDL-P
Decrease · small
Reduces atherogenic particles
Literature evidence
Endothelial function
Increase · small
Improves vascular signaling
Literature evidence
Insulin sensitivity
Increase · small
PPAR-δ metabolic effects
Literature evidence
Liver enzymes
Increase · small
Hepatic metabolism changes
Literature evidence
Keep the reference close
Track Cardarine in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.